Chronic renal disease
BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7355.85 (Published 13 July 2002) Cite this as: BMJ 2002;325:85Data supplement
Additional references
w1 Cockcroft D, Gault M. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
w2 Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D on behalf of the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70.
w3 Canadian Organ Replacement Registry. Dialysis and renal transplantation [2000 report, volume 1].Ottawa, ON: Canadian Institute for Health Information, 2000.
w4 Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al on behalf of the Modification of Diet in Renal Disease Study Group. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994;330:878-84.
w5 Ruggenenti P, Perna A, Gehrardi G, Garini G, Zoccali C, Salvadori M, et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999;354:359-64.
w6 The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
w7 Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, et al on behalf of the Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. Kidney Int 1997;52(suppl 63):S54-7.
w8 Ruggenenti P, Remuzzi G. Angiotensin-converting enzyme inhibitor therapy for non-diabetic progressive renal disease. Curr Opin Nephrol Hypertens 1997;6:489-95.
w9 The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349:1857-63.
w10 Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G on behalf of the Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Renal function and requirement for dialysis in chronic nephropathy on long-term ramipril: REIN follow-up trial. Lancet 1998;352:1252-6.
w11 Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in United States. J Am Soc Nephrol 2002;13:745-53.
w12 Binik YM, Devins GM, Barre PE, Guttmann RD, Hollomby DJ, Mandin H, et al. Live and learn: patient education delays the need to initiate renal replacement therapy in end-stage renal disease. J Nerv Ment Dis 1993;181:371-6.
w13 Obrador GT, Pereira B. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis 1998;31:398-417.
- Additional educational resources
• Tomson CRV. Recent advances: nephrology. BMJ 2000;320:98-101
• Mason PD, Pusey CD. Glomerulonephritis: diagnosis and treatment. BMJ 1994;309:1557-1563
• Walker R. Recent advances: general management of end stage renal disease. BMJ 1997;315:1429-1432
• Ifudu O. Care of patients undergoing hemodialysis. N Engl J Med 1998;339:1054-1062
• Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice: nephropathy in patients with type 2 diabetes. N Engl J Med 2002;346:1145-1151
• National Kidney Foundation—K/DOQI. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39(suppl 1):S1-266
Patient information
• National Institute of Diabetes and Digestive and Kidney Diseases (www.niddk.nih.gov/health/kidney/pubs/kidneyfailure/index.htm)—provides booklets and fact sheets in its series "Treatment Methods for Kidney Failure"
• Kidney School (www.kidneyschool.org)—an interactive, web based program designed to help people learn what they need to know to understand renal disease and its treatment, adjust to renal disease, make good medical choices, and live as fully as possible
• Doc-To-Me (www.doctome.com)—presents concise, informative, and authoritative pre–end stage renal disease lectures: "Staying healthy with bad kidneys"
• Kidney Incorporated (www.hdialysis.com)—provides general information about kidneys, pre–end stage renal disease care, and dialysis treatment
Related articles
- This Week In The BMJ Published: 13 July 2002; BMJ 325 doi:10.1136/bmj.325.7355.0/e
See more
- Generics have a chequered recent historyBMJ December 05, 2016, 355 i6527; DOI: https://doi.org/10.1136/bmj.i6527
- An older man with thoracic back painBMJ November 23, 2016, 355 i5786; DOI: https://doi.org/10.1136/bmj.i5786
- Potential role for BCG in treatment of autoimmune diseasesBMJ November 21, 2016, 355 i6091; DOI: https://doi.org/10.1136/bmj.i6091
- Risks of duloxetine for stress incontinence outweigh benefits, say researchersBMJ November 15, 2016, 355 i6103; DOI: https://doi.org/10.1136/bmj.i6103
- HaematospermiaBMJ November 10, 2016, 355 i5124; DOI: https://doi.org/10.1136/bmj.i5124
Cited by...
- Factors Associated With Self-Care Among Patients Receiving Hemodialysis: A Cross-Sectional Observational Study
- Primary Care Physicians' Knowledge and Practice Patterns in the Treatment of Chronic Kidney Disease: An Upstate New York Practice-based Research Network (UNYNET) Study
- Recurrent hypoglycaemia in a diabetic patient as a result of unexpected renal failure